Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, Saúl, Cunningham, Anthony L., Kalincik, Tomas, Havrdová, Eva Kubala, Isobe, Noriko, Pakpoor, Julia, Airas, Laura, Bunyan, Reem F., van der Walt, Anneke, Oh, Jiwon, Mathews, Joela, Mateen, Farrah J., Giovannoni, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/
https://www.ncbi.nlm.nih.gov/pubmed/34139567
http://dx.doi.org/10.1016/j.jneuroim.2021.577627
_version_ 1783704301149880320
author Reyes, Saúl
Cunningham, Anthony L.
Kalincik, Tomas
Havrdová, Eva Kubala
Isobe, Noriko
Pakpoor, Julia
Airas, Laura
Bunyan, Reem F.
van der Walt, Anneke
Oh, Jiwon
Mathews, Joela
Mateen, Farrah J.
Giovannoni, Gavin
author_facet Reyes, Saúl
Cunningham, Anthony L.
Kalincik, Tomas
Havrdová, Eva Kubala
Isobe, Noriko
Pakpoor, Julia
Airas, Laura
Bunyan, Reem F.
van der Walt, Anneke
Oh, Jiwon
Mathews, Joela
Mateen, Farrah J.
Giovannoni, Gavin
author_sort Reyes, Saúl
collection PubMed
description In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.
format Online
Article
Text
id pubmed-8183006
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-81830062021-06-07 Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement Reyes, Saúl Cunningham, Anthony L. Kalincik, Tomas Havrdová, Eva Kubala Isobe, Noriko Pakpoor, Julia Airas, Laura Bunyan, Reem F. van der Walt, Anneke Oh, Jiwon Mathews, Joela Mateen, Farrah J. Giovannoni, Gavin J Neuroimmunol Review Article In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues. Elsevier B.V. 2021-08-15 2021-06-07 /pmc/articles/PMC8183006/ /pubmed/34139567 http://dx.doi.org/10.1016/j.jneuroim.2021.577627 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Reyes, Saúl
Cunningham, Anthony L.
Kalincik, Tomas
Havrdová, Eva Kubala
Isobe, Noriko
Pakpoor, Julia
Airas, Laura
Bunyan, Reem F.
van der Walt, Anneke
Oh, Jiwon
Mathews, Joela
Mateen, Farrah J.
Giovannoni, Gavin
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
title Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
title_full Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
title_fullStr Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
title_full_unstemmed Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
title_short Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
title_sort update on the management of multiple sclerosis during the covid-19 pandemic and post pandemic: an international consensus statement
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183006/
https://www.ncbi.nlm.nih.gov/pubmed/34139567
http://dx.doi.org/10.1016/j.jneuroim.2021.577627
work_keys_str_mv AT reyessaul updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT cunninghamanthonyl updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT kalinciktomas updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT havrdovaevakubala updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT isobenoriko updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT pakpoorjulia updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT airaslaura updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT bunyanreemf updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT vanderwaltanneke updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT ohjiwon updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT mathewsjoela updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT mateenfarrahj updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement
AT giovannonigavin updateonthemanagementofmultiplesclerosisduringthecovid19pandemicandpostpandemicaninternationalconsensusstatement

Ejemplares similares